Acorah Software Products - Accounts Production 14.5.601 true true 30 November 2022 15 February 2022 false true No description of principal activity 1 December 2022 30 November 2023 30 November 2023 13916650 Mrs J L Bunyan Mr P C Bunyan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13916650 2022-11-30 13916650 2023-11-30 13916650 2022-12-01 2023-11-30 13916650 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 13916650 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 13916650 frs-bus:Micro-entities 2022-12-01 2023-11-30 13916650 frs-bus:EntityHasNeverTraded 2022-12-01 2023-11-30 13916650 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 13916650 frs-bus:Director1 2022-12-01 2023-11-30 13916650 frs-bus:Director2 2022-12-01 2023-11-30 13916650 2022-02-14 13916650 2022-11-30
Registered number: 13916650
Callisto Pharma Group Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2023
WAC (Whale & Company) Limited
Chartered Accountants & Business Advisors
Balance Sheet
Registered number: 13916650
30 November 2023 30 November 2022
£ £
Current assets 2 2
NET CURRENT ASSETS 2 2
TOTAL ASSETS LESS CURRENT LIABILITIES 2 2
NET ASSETS 2 2
CAPITAL AND RESERVES 2 2

Notes

1. General Information
Callisto Pharma Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13916650 . The registered office is The Barn, Holly Berry House, Rough Park, Hamstall Ridware, Staffordshire, WS15 3SQ.
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr P C Bunyan
Director
30th April 2024